Precision Oncology Report
: Analysis on the Market, Trends, and TechnologiesThe precision oncology ecosystem is undergoing a transformative phase, marked by the rapid expansion of companies and the integration of advanced diagnostic tools and analytics. The sector’s growth trajectory is evidenced by the significant surge in media interest and investment, with 335 companies generating approximately $4.52 billion in annual revenue. Precision oncology, part of the broader precision medicine landscape, is becoming increasingly relevant across various industries, including R&D, Biotechnology, Pharmaceuticals, and Healthcare. The market’s maturity and robust investment activity indicate a solid foundation for future healthcare advancements, with personalized care at the forefront.
The last time we updated this report was 466 days ago. If there’s something missing or off, your tips are welcome!
Topic Dominance Index of Precision Oncology
The Dominance Index for Precision Oncology merges timelines of published articles, newly founded companies, and global search data to provide a comprehensive perspective into the topic.
Key Activities and Applications
- Personalized Therapeutics: Companies are focusing on developing targeted therapies tailored to individual genetic profiles, aiming to improve patient outcomes.
- Diagnostics and Monitoring: Advanced diagnostic platforms, including liquid biopsies and genomic sequencing, are being utilized for early cancer detection and treatment monitoring.
- Drug Discovery and Development: Integration of AI and machine learning in drug discovery processes to identify novel targets and accelerate the development of precision oncology drugs.
Emergent Trends and Core Insights
- Investment in AI and Machine Learning: A noticeable trend towards leveraging AI to enhance diagnostic accuracy and predict treatment responses.
- Growth in Liquid Biopsy Technologies: Increasing adoption of non-invasive diagnostic methods that allow for early detection and real-time monitoring of cancer.
- Expansion of Genomic Data Utilization: Utilization of large-scale genomic data for personalized treatment planning and clinical decision support.
Technologies and Methodologies
- Next-Generation Sequencing (NGS): Widespread use of NGS for comprehensive genomic profiling and identification of actionable mutations.
- CRISPR and Gene Editing: Application of gene-editing technologies for research and potential therapeutic purposes.
- Bioinformatics and Data Analysis: Development of sophisticated data analysis tools to interpret complex genomic and clinical data sets.
Precision Oncology Funding
A total of 167 Precision Oncology companies have received funding.
Overall, Precision Oncology companies have raised $17.3B.
Companies within the Precision Oncology domain have secured capital from 541 funding rounds.
The chart shows the funding trendline of Precision Oncology companies over the last 5 years
Precision Oncology Companies
Delve into the corporate landscape of Precision Oncology with TrendFeedr’s Companies tool
316 Precision Oncology Companies
Discover Precision Oncology Companies, their Funding, Manpower, Revenues, Stages, and much more
Precision Oncology Investors
TrendFeedr’s Investors tool provides insights into 182 Precision Oncology investors for you to keep ahead of the curve. This resource is critical for analyzing investment activities, funding trends, and market potential within the Precision Oncology industry.
182 Precision Oncology Investors
Discover Precision Oncology Investors, Funding Rounds, Invested Amounts, and Funding Growth
Precision Oncology News
TrendFeedr’s News feature offers you access to 2.7K articles on Precision Oncology. Stay informed about the latest trends, technologies, and market shifts to enhance your strategic planning and decision-making.
2.7K Precision Oncology News Articles
Discover Latest Precision Oncology Articles, News Magnitude, Publication Propagation, Yearly Growth, and Strongest Publications
Executive Summary
Precision oncology is poised to redefine the therapeutic landscape with its focus on individualized patient care. The integration of cutting-edge technologies, such as AI, NGS, and CRISPR, along with the growth in investment and media attention, underscores the sector's potential. As companies continue to innovate and collaborate, the promise of precision oncology to deliver more effective, less invasive, and highly personalized cancer treatments is becoming a reality, offering new hope for patients and the healthcare industry as a whole.
Are you an insider in the trends or tech industry? We’d love for you to contribute to our content.
